BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23546515)

  • 1. Potential implication of IL-24 in lymphangiogenesis of human breast cancer.
    Frewer NC; Ye L; Sun PH; Owen S; Ji K; Frewer KA; Hargest R; Jiang WG
    Int J Mol Med; 2013 May; 31(5):1097-104. PubMed ID: 23546515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis.
    Mohammed RA; Green A; El-Shikh S; Paish EC; Ellis IO; Martin SG
    Br J Cancer; 2007 Apr; 96(7):1092-100. PubMed ID: 17353919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 7 upregulates vascular endothelial growth factor D in breast cancer cells and induces lymphangiogenesis in vivo.
    Al-Rawi MA; Watkins G; Mansel RE; Jiang WG
    Br J Surg; 2005 Mar; 92(3):305-10. PubMed ID: 15672426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells.
    Al-Rawi MA; Watkins G; Mansel RE; Jiang WG
    Int J Oncol; 2005 Sep; 27(3):721-30. PubMed ID: 16077922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphangiogenic characteristics of triple negativity in node-negative breast cancer.
    Liu HT; Ma R; Yang QF; Du G; Zhang CJ
    Int J Surg Pathol; 2009 Dec; 17(6):426-31. PubMed ID: 19493918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
    Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
    BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
    Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.
    Tutunea-Fatan E; Majumder M; Xin X; Lala PK
    Mol Cancer; 2015 Feb; 14():35. PubMed ID: 25744065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of lymphangiogenic markers in human gastroenteric tumor.
    Yuanming L; Feng G; Lei T; Ying W
    Arch Med Res; 2007 Jan; 38(1):106-12. PubMed ID: 17174733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
    Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
    Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.
    Van der Auwera I; Van Laere SJ; Van den Eynden GG; Benoy I; van Dam P; Colpaert CG; Fox SB; Turley H; Harris AL; Van Marck EA; Vermeulen PB; Dirix LY
    Clin Cancer Res; 2004 Dec; 10(23):7965-71. PubMed ID: 15585631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
    Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer.
    Zeng Y; Opeskin K; Baldwin ME; Horvath LG; Achen MG; Stacker SA; Sutherland RL; Williams ED
    Clin Cancer Res; 2004 Aug; 10(15):5137-44. PubMed ID: 15297417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
    Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
    Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
    Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
    Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in the atherosclerotic intima of human coronary arteries.
    Nakano T; Nakashima Y; Yonemitsu Y; Sumiyoshi S; Chen YX; Akishima Y; Ishii T; Iida M; Sueishi K
    Hum Pathol; 2005 Apr; 36(4):330-40. PubMed ID: 15891993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour.
    de la Torre NG; Buley I; Wass JA; Turner HE
    Endocr Relat Cancer; 2006 Sep; 13(3):931-44. PubMed ID: 16954441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.